T cell responses were analyzed through immunohistochemistry (IHC) staining for CD3, CD4, CD7, CD8, CD25, TIA‐1, HLA‐DR, and Ki67 (proliferative marker) on tumor biopsy samples. This evidence concerns the gene CD4 and neoplasm.